Stockscreener 앱 받기
15.95
0.82%
0.13
시간 외 거래:
15.95
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Is a Favorite Amongst Institutional Investors Who Own 54% - 富途牛牛
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - AOL.com
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - sharewise.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st
Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily
How Aurinia Pharmaceuticals Inc. (IKAP) stock trades pre earningsDebt-to-Equity Ratio Analysis & Watch and Learn From Live Trades - bollywoodhelpline.com
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month HighHere's Why - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD - Investing.com
Why Aurinia Pharmaceuticals Inc. (IKAP) stock gets analyst attentionWeekly Market Outlook & Stock Timing and Entry Methods - Улправда
Chart Watch: Will Aurinia Pharmaceuticals Inc. stock pay special dividendsWall Street Watch & Free Risk Controlled Daily Trade Plans - Улправда
Will Aurinia Pharmaceuticals Inc. stock outperform international peersWeekly Stock Recap & Weekly High Return Stock Opportunities - Bölüm Sonu Canavarı
Is Aurinia Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Sector Moves & Community Verified Watchlist Alerts - DonanımHaber
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued after correction2025 Buyback Activity & Smart Swing Trading Techniques - DonanımHaber
Will Aurinia Pharmaceuticals Inc. stock benefit from automationPortfolio Value Report & Proven Capital Preservation Methods - DonanımHaber
How Aurinia Pharmaceuticals Inc. stock responds to policy changesBreakout Watch & Safe Entry Zone Tips - Улправда
Why retail investors favor Aurinia Pharmaceuticals Inc. stockJuly 2025 Highlights & Low Risk Profit Maximizing Plans - Улправда
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Squarepoint Ops LLC - MarketBeat
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors - Yahoo Finance
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum - Yahoo Finance
How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC - MarketBeat
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Yahoo Finance
Arrowstreet Capital Limited Partnership Has $9.12 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Earnings Report: Can Aurinia Pharmaceuticals Inc stock deliver 10 annual returns2025 AllTime Highs & Long-Term Safe Investment Ideas - moha.gov.vn
State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - sharewise.com
Will Aurinia Pharmaceuticals Inc. (IKAP) stock return to pre crash levelsWeekly Trade Report & Low Risk Entry Point Guides - Newser
Can Aurinia Pharmaceuticals Inc. stock weather global recessionWeekly Trade Review & Detailed Earnings Play Alerts - Newser
How Aurinia Pharmaceuticals Inc. (IKAP) stock valuation compares with sectorJuly 2025 Action & High Accuracy Trade Signal Alerts - Newser
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 5.2%Time to Sell? - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs - MarketBeat
Can Aurinia Pharmaceuticals Inc. stock surprise with earnings upsideStock Surge & Reliable Price Breakout Signals - Newser
Aurinia Pharmaceuticals Shares Fall After Leerink Partners Downgrade - marketscreener.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛
Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns - Investing.com Canada
Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $16 From $15 - marketscreener.com
Will Aurinia Pharmaceuticals Inc. stock sustain high P E ratios2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Defamation Litigation Roundup: FDA, Lively, Alexander Bros. - Law360
Trading Systems Reacting to (AUPH) Volatility - news.stocktradersdaily.com
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com
0.90%
자본화:
|
볼륨(24시간):